Management of critical COVID-19: Acute hypoxaemic respiratory failure and COVID-19 – who.int

Overview

WHO recommends prompt recognition of progressive acute hypoxaemic respiratory
failure when a patient with respiratory distress is failing to respond to standard oxygen
therapy and adequate preparation to provide advanced oxygen/ventilatory support.

Hypoxaemic respiratory failure in ARDS commonly results from intrapulmonary
ventilation-perfusion mismatch or shunt and usually requires mechanical ventilation.

At any time, if there are urgent or emergent indications for intubation, do not delay.

We recommend prompt recognition of progressive acute hypoxaemic respiratory failure
when a patient with respiratory distress is failing to respond to standard oxygen therapy
and adequate preparation to provide advanced oxygen/ventilatory support.

WHO suggests that patients with severe or critical COVID-19 with acute hypoxaemic
respiratory failure that do not require emergent intubation be treated with HFNO, or CPAP
or NIV (BiPAP) over standard oxygen therapy.

Source